Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Shanghai Jemincare Pharmaceutical Co. Ltd. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners and 1 distinct art unit. This concentration suggests a focused prosecution strategy within a technical niche at the patent office. The presence of 2 distinct examiners for the 2 pending actions indicates that the workload is distributed across the examination staff.
NOTTINGHAM, KYLE GREGORY is identified as the busiest examiner for this portfolio. This examiner is responsible for 1 of the pending office actions. Because all activity is located within 1 distinct art unit, the company is interacting with a narrow segment of the patent office's examination staff. This allows for a consistent understanding of how this specific art unit interprets relevant pharmaceutical and biotechnological claims. Practitioners can focus their strategy on the specific tendencies of this art unit while managing the preferences of the 2 distinct examiners involved in these matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
| KIM, SEONG JONG | 1 | 25.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18720635 | CRYSTALLINE FORM OF AROMATIC RING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | NOTTINGHAM, KYLE GREGORY | — |
| 18701770 | TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | KIM, SEONG JONG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18720635 | CRYSTALLINE FORM OF AROMATIC RING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | NOTTINGHAM, KYLE GREGORY | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18720635 | CRYSTALLINE FORM OF AROMATIC RING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | NOTTINGHAM, KYLE GREGORY | — | §103§112Other | Non-Final OA | — | Pending | Jun 15, 2024 |
| 18701770 | TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | KIM, SEONG JONG | 1621 | §103§112 | Non-Final OA | — | Pending | Apr 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial